Cargando…
C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties
BACKGROUND: The medicinal effects of cannabis varieties on the market cannot be explained solely by the presence of the major cannabinoids Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD). Evidence for putative entourage effects caused by other compounds present in cannabis is hard to obtain du...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528106/ https://www.ncbi.nlm.nih.gov/pubmed/36184617 http://dx.doi.org/10.1186/s42238-022-00162-9 |
_version_ | 1784801239589978112 |
---|---|
author | van Es-Remers, Monique Spadaro, Jesus Arellano Poppelaars, Eefje Kim, Hye Kyong van Haaster, Marieke de Wit, Marcel ILiopoulou, Eva Wildwater, Marjolein Korthout, Henrie |
author_facet | van Es-Remers, Monique Spadaro, Jesus Arellano Poppelaars, Eefje Kim, Hye Kyong van Haaster, Marieke de Wit, Marcel ILiopoulou, Eva Wildwater, Marjolein Korthout, Henrie |
author_sort | van Es-Remers, Monique |
collection | PubMed |
description | BACKGROUND: The medicinal effects of cannabis varieties on the market cannot be explained solely by the presence of the major cannabinoids Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD). Evidence for putative entourage effects caused by other compounds present in cannabis is hard to obtain due to the subjective nature of patient experience data. Caenorhabditis elegans (C. elegans) is an objective test system to identify cannabis compounds involved in claimed health and entourage effects. METHODS: From a medicinal cannabis breeding program by MariPharm BV, the Netherlands a set of 12 varieties were selected both THC rich varieties as well as CBD rich varieties. A consecutive extraction process was applied resulting in a non-polar (cannabinoid-rich) and polar (cannabinoid-poor) extract of each variety. The test model C. elegans was exposed to these extracts in a broad set of bioassays for appetite control, body oscillation, motility, and nervous system function. RESULTS: Exposing C. elegans to extracts with a high concentration of cannabinoids (> 1 μg/mL) reduces the life span of C. elegans dramatically. Exposing the nematodes to the low-cannabinoid (< 0.005 μg/mL) polar extracts, however, resulted in significant effects with respect to appetite control, body oscillation, motility, and nervous system-related functions in a dose-dependent and variety-dependent manner. DISCUSSION: C. elegans is a small, transparent organism with a complete nervous system, behavior and is due to its genetic robustness and short life cycle highly suitable to unravel entourage effects of Cannabis compounds. Although C. elegans lacks an obvious CB1 and CB2 receptor it has orthologs of Serotonin and Vanilloid receptor which are also involved in (endo)cannabinoid signaling. CONCLUSION: By using C. elegans, we were able to objectively distinguish different effects of different varieties despite the cannabinoid content. C. elegans seems a useful test system for studying entourage effects, for targeted medicinal cannabis breeding programs and product development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42238-022-00162-9. |
format | Online Article Text |
id | pubmed-9528106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95281062022-10-04 C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties van Es-Remers, Monique Spadaro, Jesus Arellano Poppelaars, Eefje Kim, Hye Kyong van Haaster, Marieke de Wit, Marcel ILiopoulou, Eva Wildwater, Marjolein Korthout, Henrie J Cannabis Res Original Research BACKGROUND: The medicinal effects of cannabis varieties on the market cannot be explained solely by the presence of the major cannabinoids Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD). Evidence for putative entourage effects caused by other compounds present in cannabis is hard to obtain due to the subjective nature of patient experience data. Caenorhabditis elegans (C. elegans) is an objective test system to identify cannabis compounds involved in claimed health and entourage effects. METHODS: From a medicinal cannabis breeding program by MariPharm BV, the Netherlands a set of 12 varieties were selected both THC rich varieties as well as CBD rich varieties. A consecutive extraction process was applied resulting in a non-polar (cannabinoid-rich) and polar (cannabinoid-poor) extract of each variety. The test model C. elegans was exposed to these extracts in a broad set of bioassays for appetite control, body oscillation, motility, and nervous system function. RESULTS: Exposing C. elegans to extracts with a high concentration of cannabinoids (> 1 μg/mL) reduces the life span of C. elegans dramatically. Exposing the nematodes to the low-cannabinoid (< 0.005 μg/mL) polar extracts, however, resulted in significant effects with respect to appetite control, body oscillation, motility, and nervous system-related functions in a dose-dependent and variety-dependent manner. DISCUSSION: C. elegans is a small, transparent organism with a complete nervous system, behavior and is due to its genetic robustness and short life cycle highly suitable to unravel entourage effects of Cannabis compounds. Although C. elegans lacks an obvious CB1 and CB2 receptor it has orthologs of Serotonin and Vanilloid receptor which are also involved in (endo)cannabinoid signaling. CONCLUSION: By using C. elegans, we were able to objectively distinguish different effects of different varieties despite the cannabinoid content. C. elegans seems a useful test system for studying entourage effects, for targeted medicinal cannabis breeding programs and product development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42238-022-00162-9. BioMed Central 2022-10-03 /pmc/articles/PMC9528106/ /pubmed/36184617 http://dx.doi.org/10.1186/s42238-022-00162-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research van Es-Remers, Monique Spadaro, Jesus Arellano Poppelaars, Eefje Kim, Hye Kyong van Haaster, Marieke de Wit, Marcel ILiopoulou, Eva Wildwater, Marjolein Korthout, Henrie C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties |
title | C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties |
title_full | C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties |
title_fullStr | C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties |
title_full_unstemmed | C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties |
title_short | C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties |
title_sort | c. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528106/ https://www.ncbi.nlm.nih.gov/pubmed/36184617 http://dx.doi.org/10.1186/s42238-022-00162-9 |
work_keys_str_mv | AT vanesremersmonique celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties AT spadarojesusarellano celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties AT poppelaarseefje celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties AT kimhyekyong celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties AT vanhaastermarieke celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties AT dewitmarcel celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties AT iliopouloueva celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties AT wildwatermarjolein celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties AT korthouthenrie celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties |